Literature DB >> 8582137

Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.

B S Reisner1, A M Gatson, G L Woods.   

Abstract

The reliability of mycobacteria growth indicator tubes (MGIT) for determining the susceptibility of Mycobacterium tuberculosis to isoniazid (0.1 microgram/ml) and rifampin (2.0 micrograms/ml) was evaluated by comparing MGIT results to those obtained by the radiometric BACTEC TB method. We tested 29 isolates, many selected for resistance. The turnaround times were 3-8 days (median 6) for MGIT and 4-10 days (median 6) for BACTEC. Isoniazid results by both methods agreed for all isolates tested: 20 resistant and nine susceptible. Rifampin results agreed for 28 isolates: 10 resistant and 18 susceptible. One isolate yielded discrepant results: resistant to rifampin by BACTEC, but susceptible by MGIT. This isolate was also rifampin-resistant by the traditional Method of Proportion and when tested by the MGIT method using 1.0 micrograms/ml of rifampin. The MGIT system is a nonradiometric alternative to the BACTEC for rapid susceptibility testing of M. tuberculosis to isoniazid and rifampin; however, additional testing is needed to determine the optimal concentration of rifampin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8582137     DOI: 10.1016/0732-8893(95)00147-7

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  13 in total

1.  Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital.

Authors:  V Goloubeva; M Lecocq; P Lassowsky; F Matthys; F Portaels; I Bastian
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Performance of BACTEC 960 Mycobacteria growth indicator tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates.

Authors:  H J Marttila; M Marjamäki; M K Viljanen; H Soini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

3.  Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis.

Authors:  Kati Adjers-Koskela; Marja-Leena Katila
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  F Ardito; B Posteraro; M Sanguinetti; S Zanetti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Pretreatment of clinical specimens with sodium dodecyl (lauryl) sulfate is not suitable for the mycobacteria growth indicator tube cultivation method.

Authors:  G E Pfyffer; H M Welscher; P Kissling
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Evaluation of a new method for rapid drug susceptibility testing of Mycobacterium avium complex isolates by using the mycobacteria growth indicator tube.

Authors:  C Piersimoni; D Nista; S Bornigia; G De Sio
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

7.  High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.

Authors:  Max R O'Donnell; Julie Jarand; Marian Loveday; Nesri Padayatchi; Jennifer Zelnick; Lise Werner; Kasavan Naidoo; Iqbal Master; Garth Osburn; Charlotte Kvasnovsky; Karen Shean; Madhukar Pai; Martie Van der Walt; Charles R Horsburgh; Keertan Dheda
Journal:  Ann Intern Med       Date:  2010-10-19       Impact factor: 25.391

8.  Simple fibroblast-based assay for screening of new antimicrobial drugs against Mycobacterium tuberculosis.

Authors:  Takemasa Takii; Yoshifumi Yamamoto; Taku Chiba; Chiyoji Abe; John T Belisle; Patrick J Brennan; Kikuo Onozaki
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.

Authors:  S Rüsch-Gerdes; C Domehl; G Nardi; M R Gismondo; H M Welscher; G E Pfyffer
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.

Authors:  Max R O'Donnell; N Padayatchi; I Master; G Osburn; C R Horsburgh
Journal:  Int J Tuberc Lung Dis       Date:  2009-07       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.